Hybrid Minimally Invasive Oesophagectomy Use for Oesophageal Cancer Supported
Hybrid minimally invasive oesophagectomy (HMIO) is associated with fewer complications for resectable oesphageal cancer.
Gastrointestinal (GI) Cancers Symposium
Laproscopically Assisted Distal Gastrectomy Safe for Stage 1 Gastric Cancer
Laproscopically assisted distal gastrectomy (LADG) is safe for patients with clinical stage 1 gastric cancer.
Pembrolizumab Shows Antitumor Activity, Manageable Toxicity in Advanced Gastric Cancer
Pembrolizumab demonstrated promising antitumor activity and manageable toxicity in advanced gastric cancer.
For Gastroesophageal Adenocarcinoma, Addition of Onartuzumab to FOLFOX Does Not Improve Survival
Addition of onartuzumab to mFOLFOX6 for gastroesophageal adenocarcinoma (GEC) did not improve survival.
AMG-337 May Be Effective for MET-Amplified Gastrointestinal Tumors
AMG-337 caused responses in patients with MET-amplified gastroesophageal junction, gastric cancer, and esophageal cancer.
Novel Kinase Inhibitor Shows Efficacy in Patients with Advanced HCC Tumors Overexpressing AFP
LY2157299 monohydrate showed promising efficacy results in patients with advanced HCC tumors overexpressing AFP.
CTCs Have High Specificity for Diagnosis of Pancreatic Ductal Adenocarcinoma
Circulating tumor cells are a useful adjunct in the diagnosis of pancreatic ductal adenocarcinoma.
PET/CT Can Prevent ‘Futile Laparotomy’ in Resectable/Borderline Pancreatic Cancer
PET/CT may prevent unnecessary laparotomy by detecting occult metastatic disease in patients with resectable/borderline pancreatic cancer.
Nab-Paclitaxel Plus Gemcitabine Sustains OS in Metastatic Pancreatic Adenocarcinoma
Nab-paclitaxel plus gemcitabine sustained overall survival rates compared with gemcitabine alone in patients with metastatic pancreatic adenocarcinoma.
Cetuximab Does Not Improve FOLFOX4 Outcomes for CRC with RAS Mutations
Cetuximab should not be added to first-line FOLFOX4 for patients whose mCRC harbors RAS mutations.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in GI Cancers Symposium 2014
Loading... 
Loading...